Does Dr. TINA ABRAHAM have financial conflicts of interest?

Dr. TINA ABRAHAM (D.O.) has received a total of $667,415 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $667,415 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. TINA ABRAHAM?

According to CMS Open Payments data, Dr. TINA ABRAHAM received funding from ASTRAZENECA PHARMACEUTICALS ($329,036), REGENERON HEALTHCARE SOLUTIONS ($170,266), and GENZYME CORPORATION ($97,130).

Does Dr. TINA ABRAHAM receive research grants or speaking fees?

Dr. TINA ABRAHAM has received $667,415 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. TINA ABRAHAM

D.O.Real-Time Hydrated

Specialty: Internal Medicine

Practice Location: PONTIAC, MI 48342

NPI Number: 1215376108

LIFETIME INDUSTRY VALUE

$667,415

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABRAHAM is a verified Internal Medicine practitioner based in PONTIAC, MI.

Between 2021 and 2024, Dr. ABRAHAM had an overall industry promotional and research financial footprint of $667,415 as recorded in the federal CMS Open Payments database.

$667,415 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABRAHAM's primary funding source is ASTRAZENECA PHARMACEUTICALS, which accounts for $329,036 (representing 49.3% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ASTRAZENECA PHARMACEUTICALS

Rank 1

$329,036

49.3%

REGENERON HEALTHCARE SOLUTIONS

Rank 2

$170,266

25.5%

GENZYME CORPORATION

Rank 3

$97,130

14.6%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.